There are a wide variety of sensitivities and specificities reported in the literature for colorectal cancer detection in symptomatic patients (85 to 100% and 56 to 91% respectively at ≥ 10 μg Hb /g faeces threshold) [8–15]. This evidence concerns the gene GSTM1 and colorectal cancer.